Tenaya Therapeutics (TNYA) Non-cash Items (2020 - 2025)

Tenaya Therapeutics has reported Non-cash Items for 6 years, with the latest figure at $7.1 million in Q4 2025.

• For the quarter ending Q4 2025, Non-cash Items rose 1656.48% year-over-year to $7.1 million; the trailing twelve-month figure through Dec 2025 stood at $7.1 million (up 1656.48% YoY), and the FY2025 full-year result was $7.1 million, up 33.54% from the prior year.
• Non-cash Items for Q4 2025 stood at $7.1 million, up from $406000.0 in the prior quarter.
• The five-year high for Non-cash Items was $25.0 million in Q4 2023, with the low at $406000.0 in Q4 2024.
• Average Non-cash Items over 5 years is $8.2 million, with a median of $7.1 million recorded in 2025.
• Year-over-year, Non-cash Items sank 98.38% in 2024 and soared 1656.48% in 2025.
• Tracing TNYA's Non-cash Items over 5 years: stood at $705577.0 in 2021, then soared by 143.71% to $1.7 million in 2022, then soared by 1353.88% to $25.0 million in 2023, then slumped by 98.38% to $406000.0 in 2024, then soared by 1656.48% to $7.1 million in 2025.
• The last three Non-cash Items figures came in at $7.1 million (Q4 2025), $406000.0 (Q4 2024), and $25.0 million (Q4 2023), per Business Quant data.

Peer Comparison